Approval · Notice of Compliance 31385 · 2023
JAMP DIGOXIN: Notice of Compliance 31385
Issued August 4, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31385
- Date
- August 4, 2023
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Updates to the bottle labels
- Canadian reference product
- TOLOXIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP DIGOXIN | Not yet assigned | — |